Prognostic utility of combined suPAR and procalcitonin levels for mortality prediction in sepsis patients
Open Access
- 2 June 2026
- journal article
- Published by Taylor & Francis in All Life
- Vol. 19 (1)
Abstract
No abstract availableFunding Information
- Universitas Brawijaya (697.13/UN10.C10/PN/2019)
This publication has 34 references indexed in Scilit:
- Biomarkers in sepsisClinica Chimica Acta, 2024
- Sepsis heterogeneityWorld Journal of Pediatrics, 2023
- Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysisIntensive Care Medicine, 2020
- SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort studyScientific Reports, 2019
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Comparison of qSOFA and SOFA score for predicting mortality in severe sepsis and septic shock patients in the emergency department of a low middle income countryTurkish Journal of Emergency Medicine, 2018
- Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional studyThe Lancet Global Health, 2017
- suPAR: The unspecific marker for disease presence, severity and prognosisInternational Journal of Antimicrobial Agents, 2015
- Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patientsJournal of Critical Care, 2014
- Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndromeClinical Biochemistry, 2013